Atrial fibrillation (AFIB) is the most common heart rhythm abnormality and is associated with significant morbidity and mortality. While the treatment of AFIB involves strategies of rate with or without rhythm control, it is also essential to strategize appropriate therapies to prevent thromboembolic complications arising from AFIB. Previously, anticoagulation was the main treatment option which exposed patients to higher than usual risk of bleeding. However, with the advent of new technology, novel therapeutic options aimed at surgical or percutaneous exclusion or occlusion of the left atrial appendage in preventing thromboembolic complications from AFIB have evolved. This review evaluates recent advances and therapeutic options in treating AFIB with a special focus on both surgical and percutaneous interventions which can reduce and/or eliminate thromboembolic complications of AFIB.
| Identifer | oai:union.ndltd.org:ETSU/oai:dc.etsu.edu:etsu-works-10606 |
| Date | 01 December 2020 |
| Creators | Riddle, Malini, McCallum, Richard, Ojha, Chandra Prakash, Paul, Timir Kumar, Gupta, Vineet, Baran, David Alan, Prakash, Bharat Ved, Misra, Amogh, Mares, Adriana Camila, Abedin, Moeen, Kedar, Archana, Mulukutla, Venkatachalam, Ibrahim, Ahmed, Nagarajarao, Harsha |
| Publisher | Digital Commons @ East Tennessee State University |
| Source Sets | East Tennessee State University |
| Detected Language | English |
| Type | text |
| Source | ETSU Faculty Works |
Page generated in 0.0023 seconds